Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ORYZANOL INDUSTRY
2.1 Summary about Oryzanol Industry
2.2 Oryzanol Market Trends
2.2.1 Oryzanol Production & Consumption Trends
2.2.2 Oryzanol Demand Structure Trends
2.3 Oryzanol Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pharmaceutical Grade
4.2.2 Food Grade
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pharmaceuticals
4.3.2 Cosmetics
4.3.3 Food Supplement
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pharmaceutical Grade
5.2.2 Food Grade
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pharmaceuticals
5.3.2 Cosmetics
5.3.3 Food Supplement
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pharmaceutical Grade
6.2.2 Food Grade
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pharmaceuticals
6.3.2 Cosmetics
6.3.3 Food Supplement
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pharmaceutical Grade
7.2.2 Food Grade
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pharmaceuticals
7.3.2 Cosmetics
7.3.3 Food Supplement
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pharmaceutical Grade
8.2.2 Food Grade
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pharmaceuticals
8.3.2 Cosmetics
8.3.3 Food Supplement
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pharmaceutical Grade
9.2.2 Food Grade
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pharmaceuticals
9.3.2 Cosmetics
9.3.3 Food Supplement
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Oryza Oil & Fat Chemical
10.1.2 TSUNO
10.1.3 Henry Lamotte OILS
10.1.4 Okayasu Shorten
10.1.5 Delekang Food
10.1.6 Jining Ankang Pharmaceutical
10.1.7 Kangcare
10.1.8 Huadong Medicine Group Wufeng Pharmaceutical
10.2 Oryzanol Sales Date of Major Players (2017-2020e)
10.2.1 Oryza Oil & Fat Chemical
10.2.2 TSUNO
10.2.3 Henry Lamotte OILS
10.2.4 Okayasu Shorten
10.2.5 Delekang Food
10.2.6 Jining Ankang Pharmaceutical
10.2.7 Kangcare
10.2.8 Huadong Medicine Group Wufeng Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT